• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, Jan. 23

Elder Pharmaceuticals has posted a 35.66-per cent rise in net profit at Rs 14.57 crore (Rs 10.74 crore) for the third quarter ended December 31. Net sales grew 31.72 per cent to Rs 115.69 crore (Rs 87.83 crore). The earnings per share stands at Rs 7.84.

During the quarter, Elder entered into a marketing pact with F Hoffman La Roche for Bon Viva, a drug for osteoporosis. Elder's focus areas in the years to come shall be diabetology and cardiology, the company said in a press release. Shares of the company fell 2.79 per cent to close at Rs 415.75 on BSE.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Grasim Q3 net doubles on higher sales realisations

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line